Paxman AB (PXMBF)
3.50
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Paxman Net Income (Quarterly) : 0.2737M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2737M |
| March 31, 2026 | -0.0137M |
| December 31, 2025 | -0.9313M |
| September 30, 2025 | 0.1333M |
| June 30, 2025 | -0.338M |
| March 31, 2025 | -0.516M |
| December 31, 2024 | 1.130M |
| September 30, 2024 | 0.4796M |
| June 30, 2024 | 0.9184M |
| March 31, 2024 | 1.261M |
| December 31, 2023 | -0.1543M |
| September 30, 2023 | 0.6809M |
| June 30, 2023 | 0.488M |
| March 31, 2023 | -0.2424M |
| December 31, 2022 | -0.9106M |
| September 30, 2022 | 0.4409M |
| June 30, 2022 | 0.0609M |
| March 31, 2022 | -0.6644M |
| December 31, 2021 | -0.1497M |
| Date | Value |
|---|---|
| September 30, 2021 | -0.6073M |
| June 30, 2021 | -0.6501M |
| March 31, 2021 | -0.0866M |
| December 31, 2020 | -1.284M |
| September 30, 2020 | -0.4778M |
| June 30, 2020 | -0.6689M |
| March 31, 2020 | 0.2652M |
| December 31, 2019 | 0.219M |
| September 30, 2019 | 0.0882M |
| June 30, 2019 | 0.031M |
| March 31, 2019 | -0.0533M |
| December 31, 2018 | -0.4715M |
| September 30, 2018 | -0.0339M |
| June 30, 2018 | -0.10M |
| March 31, 2018 | -0.2051M |
| December 31, 2017 | -0.7242M |
| September 30, 2017 | -0.2142M |
| June 30, 2017 | -0.0449M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Getinge AB | 89.59M |
| Xvivo Perfusion AB | 1.739M |
| Abbott Laboratories | 928.00M |
| AngioDynamics, Inc. | -7.097M |
| Alphatec Holdings, Inc. | -25.78M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 11.21M |
| Total Expenses (Quarterly) | 10.94M |
| EPS Diluted (Quarterly) | 0.0117 |
| Enterprise Value | 71.82M |
| Gross Profit Margin (Quarterly) | 3.65% |
| Profit Margin (Quarterly) | 2.44% |
| Earnings Yield | -0.65% |
| Operating Earnings Yield | 0.26% |
| Normalized Earnings Yield | -0.6571 |